These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1280507)

  • 81. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
    Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
    J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Performance Evaluation of Protein Chip Assay for Rapid Diagnosis of Hepatitis C Virus Infection in Injection Drug Abusers.
    Dai Z; Shu X; Li G; Xi W
    Clin Lab; 2018 Apr; 64(4):527-534. PubMed ID: 29739068
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reliability of immunoassays for anti-HCV antibodies (ELISA and RIBA II) in patients with essential mixed cryoglobulinemia (EMC).
    Monteverde A; Airoldi G; Ballarè M; Fortina G; Quaglia V; Pigatto A; Manzini P
    Clin Exp Rheumatol; 1993; 11(6):609-13. PubMed ID: 7507807
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR.
    Tucker TJ; Voigt M; Bird A; Robson S; Gibbs B; Kannemeyer J; Galloway M; Kirsch RE; Smuts H
    S Afr Med J; 1997 May; 87(5):603-5. PubMed ID: 9254818
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hepatitis C virus among blood donors: follow-up study.
    Alonso C; Pedroso ML; de Sanjosé S; Montcharmont P; Chèvre JM; Boucaud MJ; Lambert V; Cortey ML; Trépo C
    Transfusion; 1994 Jun; 34(6):527-30. PubMed ID: 8023395
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Kasahara A; Fusamoto H; Ohtani S; Okubo Y; Kamada T
    Vox Sang; 1994; 67(3):280-5. PubMed ID: 7532341
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
    Monteleone PM; Andrzejewski C; Kelleher JF
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].
    Bonaguidi-Magniaux M; Pilette C; Oberti F; Bidet ML; Calès P
    Gastroenterol Clin Biol; 1996; 20(8-9):663-8. PubMed ID: 8977814
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
    Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
    Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Failure to detect vertical transmission of hepatitis C virus.
    Reinus JF; Leikin EL; Alter HJ; Cheung L; Shindo M; Jett B; Piazza S; Shih JW
    Ann Intern Med; 1992 Dec; 117(11):881-6. PubMed ID: 1332561
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
    Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
    Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Screening tests of anti-HVC antibodies used in France. Analysis of sensitivity].
    Janot C; Couroucé AM; Barin F; Lunel-Fabiani F; Trépo C; Botté C
    Transfus Clin Biol; 1994; 1(4):295-301. PubMed ID: 7522849
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Recombinant immunoblot assay for hepatitis C virus antibody in chronic hepatitis.
    Taliani G; Badolato MC; Lecce R; De Bac C; De Marzio E; Balsano C; Artini M; Levrero M
    Arch Virol Suppl; 1992; 4():232-3. PubMed ID: 1450692
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Serological diagnosis of anti-HCV antibodies. Tests for screening and confirmation: analytical study. Le groupe "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):163-9. PubMed ID: 1329791
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [European Acute Transfusion Hepatitis Interferon Study (EATHIS)].
    Jullien AM; Dejean AM; Janot C; Trepo C
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):199-204. PubMed ID: 1329792
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1998; (62):237-49. PubMed ID: 9507813
    [No Abstract]   [Full Text] [Related]  

  • 99. Blood-bank testing for infectious diseases: how safe is blood transfusion?
    Strong DM; Katz L
    Trends Mol Med; 2002 Jul; 8(7):355-8. PubMed ID: 12114117
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinical and serological courses of a newborn with post-transfusion hepatitis C.
    Maniwa H; Miyake Y; Hamada M; Oda T; Li R; Yokoyama T; Sugiyama K; Wada Y
    J Viral Hepat; 1995; 2(6):303-5. PubMed ID: 8732177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.